The U.S. Centers for Disease Control and Prevention formally lifted its pause on the Johnson & Johnson vaccine after a panel on Friday recommended resuming its use, despite a very rare risk of blood clots. The panel said Friday that the vaccine’s benefits outweigh the serious but small risk. The Western States Scientific Safety Review Workgroup also completed its review of the federal process and has unanimously concluded that use of the Johnson & Johnson COVID-19 vaccine should resume in the Western States. Governor Gavin Newsom confirmed Saturday the vaccine is available for use again in California.